367.20

Content Details
Information on this page was last modified on : 2023/11/21 1:59:47 AM

Lobion-HRT tablet 2.5 mg 3×10’s

(1 customer review)

Lobion-HRT tablet contains Tibolone | belongs to Gonadomimetic

Alternate brands of Lobion-HRT tablet 2.5 mg 3×10’s

Brand Name Price Savings
Tibopause tablet 2.5 mg 3×10’s  367.21 You will pay -0.0099999999999909 more
Tibol tablet 2.5 mg 28’s  915.78 You will pay -548.58 more
List of alternate brands

How it works

Lobion-HRT tablet 2.5 mg 3×10’s enhance testosterone availability by reducing sex hormone binding globulin (SHBG).

Side effects

Major & minor side effects for Lobion-HRT tablet 2.5 mg 3×10’s

  • Abnormal hair growth
  • Lower abdominal pain
  • Vaginal discharge
  • Breast tenderness
  • Genital itching
  • Vaginal bleeding
  • Pelvic pain
  • Weight gain
  • Acne
  • Abdominal discomfort
  • Nipple pain

Uses of Lobion-HRT tablet 2.5 mg 3×10’s

What is it prescribed for?

  • Oestrogen deficiency

    This medicine is used for treating the symptoms of estrogen deficiency in postmenopausal women, more than one year after menopause.

  • Prevention of osteoporosis

    This medicine is used for the prevention of osteoporosis in postmenopausal women who are at a high risk of features and intolerant for other medicines approved for the prevention of osteoporosis.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains effective in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women.

When not to use?

  • Breast cancer

    This medicine is not recommended for use in patients with known, past or suspected breast cancer due to the increased risk of worsening of the patient's condition.

  • Endometrial cancer

    This medicine is not recommended for use in patients with endometrial cancer due to the increased risk of worsening of the patient's condition.

  • Genital bleeding

    This medicine is not recommended for use if you have abnormal genital bleeding which was not diagnosed due to the increased risk of worsening the patient's condition.

  • Endometrial hyperplasia

    This medicine is not recommended for use in patients with endometrial hyperplasia due to the increased risk of worsening the patient's condition.

  • Venous thromboembolic events

    This medicine is not recommended for use in patients with previous or current thromboembolism due to the increased risk of worsening of the patient's condition.

  • Arterial thromboembolic disease

    This medicine is not recommended for use in patients with a known history of arterial thromboembolic diseases such as angina, stroke, myocardial infarction, etc. due to the increased risk of worsening of the patient's condition.

  • Acute liver disease

    This medicine is not recommended for use in patients having an acute liver disease due to the increased risk of worsening of the patient's condition.

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Lobion-HRT tablet 2.5 mg 3×10’s or any other inactive ingredients present along with it.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women.

General Warnings
  • Breast cancer

    This medicine should not be used in patients with previous history or current symptoms of breast cancer due to the increased risk of recurrence of the disease, especially in postmenopausal women. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Limitations of use

    This medicine is recommended for use in postmenopausal women only. It is not intended for contraceptive use.

  • Kidney Disease

    This medicine should be used with caution in patients with kidney diseases due to the increased risk of adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Other medicines

    This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

  • Use in Children

    This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Dosage

  • Missed Dose

    Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Phenobarbital
  • Phenytoin
  • Carbamazepine
  • Rifampicin
  • Warfarin

General Instructions

Take this medicine with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine before completion of the course/without consulting your doctor.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information:

what are the adverse effects of Lobion-HRT tablet 2.5 mg 3×10’s?

Changes in body weight. Dizziness, headache, migraine, visual disturbance. Seborrhoeic dermatitis, skin irritation. Vaginal bleeding. GI disturbances. Abnormal liver function. Hirsutism, pretibial oedema.

What happens if I miss a dose of Lobion-HRT tablet 2.5 mg 3×10’s?

Adults: 1 tab daily for minimum 3 mth. Children: Not applicable.

One of the following licensed pharmacy from the nearest location will deliver Lobion-HRT tablet 2.5 mg 3×10’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

1 review for Lobion-HRT tablet 2.5 mg 3×10’s

  1. Omran Babar

    Please deliver original and genuine medicine thanks.

Add a review
Shopping Cart